These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7769877)

  • 1. [Clinical trials with drugs: the influence of the authorization process].
    Carcas AJ; Serrano MA; Avendaño C; Galende I; Tristán C; García-Alonso F
    Med Clin (Barc); 1995 May; 104(18):683-8. PubMed ID: 7769877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The quality of clinical trials published in Spain: an evaluation by an analysis of 3 journals during the 1985-1991 period].
    Soto J; Galende I; Sacristán JA
    Med Clin (Barc); 1994 Feb; 102(7):241-5. PubMed ID: 8170209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of legal regulations on the quality of clinical trials carried out in Spain].
    García López FJ
    Med Clin (Barc); 1993 May; 100(20):770-7. PubMed ID: 8321053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trials published in Revista Española de Anestesiología y Reanimación: characteristics and quality of design].
    García-Alamino JM; Parera A; Ollé G; Bonfill X
    Rev Esp Anestesiol Reanim; 2007; 54(6):333-9. PubMed ID: 17695943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals.
    Thakur A; Wang EC; Chiu TT; Chen W; Ko CY; Chang JT; Atkinson JB; Fonkalsrud EW; Grosfeld JL
    J Pediatr Surg; 2001 Aug; 36(8):1160-4. PubMed ID: 11479847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacy Department standard procedures for clinical trial development].
    Pérez Peiró C; Porta Oltra B; Cholvi Llovell M; Jiménez Torres NV
    Farm Hosp; 2004; 28(1):36-47. PubMed ID: 15012177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [International diffusion of clinical trials carried out in Spain. An analysis based on their publication in scientific journals].
    Baños JE; Bosch F; Bigorra J; Guardiola E
    Med Clin (Barc); 1994 Apr; 102(12):441-5. PubMed ID: 8207992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differences in the quality of Spanish clinical trials published in international periodicals and of the ones presented in general medicine periodicals with wide readership].
    Delgado Rodríguez M; Ruiz-Canela M; de Irala-Estévez J; Llorca Díaz J; Martínez-González MA
    Rev Clin Esp; 2001 Aug; 201(8):437-43. PubMed ID: 11599154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
    Ekimoto H
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials in Israel. Criteria for approval.
    Nir I
    Isr J Med Sci; 1983 May; 19(5):445-8. PubMed ID: 6862851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis of patient information sheets for obtaining informed consent in clinical trials].
    Ordovás Baines JP; López Briz E; Urbieta Sanz E; Torregrosa Sánchez R; Jiménez Torres NV
    Med Clin (Barc); 1999 Jan; 112(3):90-4. PubMed ID: 10074615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre trials review process by research ethics committees in Spain: where do they stand before implementing the new European regulation?
    Dal-Ré R; Ortega R; Morejón E
    J Med Ethics; 2005 Jun; 31(6):344-50. PubMed ID: 15923484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM; Sandler AB
    J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEC-net: the development of the European register of clinical trials on medicines for children.
    Santoro E; Rossi V; Pandolfini C; Bonati M
    Clin Trials; 2006; 3(4):366-75. PubMed ID: 17060211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is proper methodology associated with the use of a clinically relevant outcome measure? The case of randomized clinical trials on medical treatment of open-angle glaucoma.
    Rossetti L; Marchetti I; Orzalesi N; Scorpiglione N; Liberati A
    Online J Curr Clin Trials; 1993 Nov; Doc No 100():[6512 words; 199 paragraphs]. PubMed ID: 8305993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological quality and reporting of ethical requirements in phase III cancer trials.
    Tuech JJ; Pessaux P; Moutel G; Thoma V; Schraub S; Herve C
    J Med Ethics; 2005 May; 31(5):251-5. PubMed ID: 15863678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality control in clinical trials].
    Fukushima M
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):172-82. PubMed ID: 8611045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.